MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

Search

Perrigo Co PLC

Închisă

SectorSănătate

10.73 9.94

Rezumat

Modificarea prețului

24h

Curent

Minim

9.75

Maxim

10.79

Indicatori cheie

By Trading Economics

Venit

-1.4B

-1.4B

Vânzări

66M

1.1B

EPS

0.77

Randament dividend

12.17

Marjă de profit

-127.478

Angajați

8,100

EBITDA

-1.4B

-1.2B

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+64.61% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

12.17%

2.45%

Următoarele câștiguri

6 mai 2026

Data viitoare de dividende

16 iun. 2026

Următoarea dată ex-dividende

29 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-664M

1.3B

Deschiderea anterioară

0.79

Închiderea anterioară

10.73

Sentimentul știrilor

By Acuity

23%

77%

66 / 349 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Perrigo Co PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 iul. 2025, 13:01 UTC

Achiziții, Fuziuni, Preluări

Perrigo to Sell Dermacosmetics Business to KKR With Focus on Streamlining Company

14 iul. 2025, 12:33 UTC

Achiziții, Fuziuni, Preluări

Perrigo: Business Generated About 5% of 2024 Adjusted Operating Income >PRGO

14 iul. 2025, 12:33 UTC

Achiziții, Fuziuni, Preluări

Perrigo: Dermacosmetics Branded Business Generated About EUR125 Million Sales in 2024 >PRGO

14 iul. 2025, 12:32 UTC

Achiziții, Fuziuni, Preluări

Perrigo: Deal Proceeds to Further Strengthen Balance Sheet >PRGO

14 iul. 2025, 12:31 UTC

Achiziții, Fuziuni, Preluări

Perrigo: Deal Includes EUR300 Million Upfront Cash, Up to EUR27 Million Contingent Payments >PRGO

14 iul. 2025, 12:31 UTC

Achiziții, Fuziuni, Preluări

Perrigo To Sell Dermacosmetics Branded Business to KKR Investment Vehicle >PRGO

14 iul. 2025, 12:30 UTC

Achiziții, Fuziuni, Preluări

Perrigo Announces Agreement to Divest Dermacosmetics Business for Up to EUR327 Million

Comparație

Modificare preț

Perrigo Co PLC Așteptări

Obiectiv de preț

By TipRanks

64.61% sus

Prognoză pe 12 luni

Medie 16 USD  64.61%

Maxim 17 USD

Minim 15 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPerrigo Co PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

1

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

25.22 / 26.85Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

66 / 349 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
help-icon Live chat